Health state utilities for non small cell lung cancer

@article{Nafees2008HealthSU,
  title={Health state utilities for non small cell lung cancer},
  author={Beenish Nafees and Megan R Stafford and Sonia Gavriel and Shkun Bhalla and Jessamy Watkins},
  journal={Health and Quality of Life Outcomes},
  year={2008},
  volume={6},
  pages={84 - 84}
}
BACKGROUND Existing reports of utility values for metastatic non-small cell lung cancer (NSCLC) vary quite widely and are not all suitable for use in submissions in the UK. The aim of this study was to elicit UK societal based utility values for different stages of NSCLC and different grade III-IV toxicities commonly associated with chemotherapy treatments. Toxicities included neutropenia, febrile neutropenia, fatigue, diarrhoea, nausea and vomiting, rash and hair loss. METHODS Existing… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 85 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Development and elicitation of health state utilities in Metastatic Non Small cell lung cancer (NSCLC) in the UK

  • A Lloyd, P van Hanswijck de Jonge, S Doyle, M Walker, C Farina
  • Poster presented at: The 27th Annual Meeting of…
  • 2005
Highly Influential
4 Excerpts

Clinical interpretation of quality of life outcomes : investigation in a randomized trial of gemcitabine plus paclitaxel compared to paclitaxel alone for metastatic breast cancer ( MBC )

  • GW Torrance
  • Annals of Oncology
  • 2004

Clinical interpretation of quality of life outcomes: investigation in a randomized trial of gemcitabine plus paclitaxel compared to paclitaxel alone for metastatic breast cancer

  • P Hopwood, J Watkins, P Ellis, I Smith
  • (MBC). Annals of Oncology 2004,
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…